Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
7h
Lenz Therapeutics announces FDA acceptance of NDA for LNZ100
LENZ Therapeutics (LENZ) announced that the U.S. Food and Drug Administration, FDA, has accepted the Company’s New Drug Application, NDA, for LNZ100 for the treatment of presbyopia, a condition ...
Monthly Prescribing Reference
16h
Aceclidine-Based Eye Drop Under Review for Presbyopia
LNZ100 is a single-use, once-daily eye drop containing aceclidine, a small molecule acetylcholine receptor agonist that causes miosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Arrested in trafficking case
Sued by Murdoch’s firms
To headline 2 Harris rallies
Crew ID’d in WA jet crash
Arizona official pleads guilty
Splits with NY magazine
1st trans lawyer at SCOTUS
Copyright infringement suit
Target to cut prices
Reveals 2025 tax brackets
Washington state shooting
Recalled over listeria risk
Right whale population rises
Overseas ballot suits denied
Meteorite aided early life?
China holds live-fire drills
Fuel pump concern recall
$400M aid package for UKR
FTC bans fake reviews
Blinken arrives in Israel
Infant mortality increased
Extends student loan pause
US data protection move
Raises US growth forecast
Tests facial recognition tech
Probing leak of US intel
Peru ex-president sentenced
PA political threat case
SK mulls arms for Ukraine
2025 Medicare changes
Same-day pharmacy delivery
Feedback